Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01774786 |
|---|---|
| Brief Title: | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer (JACOB) |
| First Submitted : | January 21, 2013 |
| First Submitted that Met QC Criteria : | January 21, 2013 |
| First Posted : | January 24, 2013 (Estimate) |
| Results First Submitted : | December 8, 2017 |
| Results First Submitted that Met QC Criteria : | January 17, 2018 |
| Results First Posted : | February 14, 2018 |
| Last Update Submitted that Met QC Criteria : | December 3, 2020 |
| Last Update Posted : | December 30, 2020 |